Therapeutics: MicroRNA-1246 (miR-1246); miR-1290

Cancer

INDICATION: Non-small cell lung cancer (NSCLC)

Patient sample, cell culture and mouse studies suggest inhibiting miR-1246 or miR-1290

Read the full 173 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE